Cytarabine Injection, Solution
Product Images NDC 71288-168

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 71288-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cyt07 0000 01 V2)

Chemical structure of Cytarabine, showing the molecular formula C9H13N3O5 and molecular weight 243.22. The structure depicts the arrangement of atoms and bonds in the Cytarabine molecule.*

FDA Label Image

Cyt07 0000 02 V3

Label for Cytarabine injection 1,000 mg per 50 mL (20 mg/mL) in a 50 mL bottle by Meitheal Pharmaceuticals Inc. The label indicates this is a pharmacy bulk package not for direct infusion, for intravenous and subcutaneous use. It includes caution text noting cytotoxicity and the NDC 71288-168-50.*

FDA Label Image

Cyt07 0000 03 V2

Carton label for Cytarabine Injection 1,000 mg per 50 mL (20 mg/mL) solution, for intravenous and subcutaneous use. The pharmacy bulk package is marked with caution notes stating it is not for direct infusion and is a cytotoxic agent. Labeler is Meitheal Pharmaceuticals Inc. The package includes barcode, storage instructions, ingredient information, and lot/expiration placeholders for presentation purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.